Tristan van Doormaal

Founder and Chief Medical Officer at Augmedit

Tristan van Doormaal has extensive experience in the field of neurosurgery. Tristan is currently working as a Neurosurgeon at Universitätsspital Zürich since September 2019. Prior to this, they founded Augmedit B.V. in July 2019 and served as the Chief Medical Officer, where they developed Augmented Reality applications for surgeons. Tristan has also worked at UMC Utrecht for several years, starting in 2007. At UMC Utrecht, they had multiple roles including Neurosurgeon, Associate Professor, Principle Investigator for the ENCASE trial, and Resident Neurosurgery. Tristan also worked as a Research Scientist at BTI - Brain Technology Institute from January 2013 to July 2019. Tristan completed a Stereotactic Neuroradiosurgery Fellowship at the Ohio State University Comprehensive Cancer Center-James Cancer Hospital & Solove Research Institute in 2015. Tristan began their career as a Resident Neurosurgery at St. Elisabeth Ziekenhuis in 2012. Tristan van Doormaal's work experience demonstrates their dedication and expertise in the field of neurosurgery.

Tristan van Doormaal's education history is as follows:

In 1998, they obtained a Bachelor's degree in Medicine from Transnationale Universiteit Limburg Diepenbeek. Tristan then pursued further studies at Radboud University from 2000 to 2006, where they earned a Doctor of Medicine (MD) degree, specializing in the field of Medicine.

Following that, Tristan enrolled at Utrecht University from 2007 to 2010 and successfully completed their Doctor of Philosophy (PhD) in Neuroscience.

Later, from 2010 to 2015, they attended Utrecht University once again and attained a degree in Neurosurgery.

Most recently, in the year 2020, Tristan took a course at Scrum 101 and obtained a Professional Scrum Product Owner certification.

These are the educational milestones of Tristan van Doormaal, as per the provided chronological information.

Links

Peers

View in org chart

Timeline

  • Founder and Chief Medical Officer

    July, 2019 - present